$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Abuse-resistant amphetamine prodrugs

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-038/00
  • A61K-051/00
  • A61K-031/785
  • G01N-033/53
  • G01N-033/00
출원번호 UP-0202146 (2008-08-29)
등록번호 US-7678771 (2010-04-21)
발명자 / 주소
  • Mickle, Travis
  • Krishnan, Suma
  • Bishop, Barney
  • Lauderback, Christopher
  • Moncrief, James Scott
  • Oberlender, Robert
  • Piccariello, Thomas
  • Paul, Bernhard J.
  • Verbicky, Christopher A.
출원인 / 주소
  • Shire LLC
대리인 / 주소
    Darby & Darby P.C.
인용정보 피인용 횟수 : 20  인용 특허 : 67

초록

The invention describes compounds, compositions, and methods of using the same comprising a chemical moiety covalently attached to amphetamine. These compounds and compositions are useful for reducing or preventing abuse and overdose of amphetamine. These compounds and compositions find particular u

대표청구항

The invention claimed is: 1. A composition comprising from 25 to 75 mg of L-lysine-d-amphetamine or a salt thereof and having an amphetamine base amount of from 7.37 to 22.1 mg of said amphetamine, said L-lysine-d-amphetamine or a salt thereof providing at least five properties selected from the gr

이 특허에 인용된 특허 (67)

  1. Mickle,Travis; Krishnan,Suma; Bishop,Barney; Lauderback,Christopher; Moncrief,James Scott; Oberlender,Rob; Piccariello,Thomas, Abuse-resistant amphetamine compounds.
  2. Piccariello, Thomas; Olon, Lawrence P.; Kirk, Randall J., Active agent delivery systems and methods for protecting and administering active agents.
  3. Buechler Kenneth F. (San Diego CA) Noar Joseph B. (Solana Beach CA) Moi Si S. (Escondido CA), Amphetamine derivatives and protein and polypeptide amphetamine derivative conjugates and labels.
  4. Miyazaki Jinsei (Higashiosaka JPX) Taketani Makoto (Ashiya JPX) Mitsumata Tadayasu (Hirakata JPX), Amphetamine protein complex as immunogen for obtaining antibodies specific to methamphetamine.
  5. Miyazaki Jinsei (Higashiosaka JPX) Taketani Makoto (Ashiya JPX) Mitsumata Tadayasu (Hirakata JPX), Amphetamine-protein complex as immunogen for obtaining antibodies specific to methamphetamine.
  6. Ekwuribe Nnochiri ; Ramaswamy Muthukumar ; Rajagopalan Jayanthi Sethuraman, Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same.
  7. Swadesh Joel K. ; Sevoian Martin, Antigen-processing cell-targeted conjugates.
  8. Arimilli Murty N. ; Cundy Kenneth C. ; Dougherty Joseph P. ; Kim Choung U. ; Oliyai Reza ; Stella Valentino J., Antiviral phosphonomethoxy nucleotide analogs having increased oral bioavailability.
  9. Kohn Joachim B. (Highland Park NJ) Langer Robert S. (Somerville MA) Niemi Steven M. (Sudbury MA) Fox James G. (Littleton MA), Biodegradable polymeric drug delivery system with adjuvant activity.
  10. Bichon Daniel (Les Lieux dits “Les Chenevires”16 ; rue de Vallard 74240 Gaillard FRX) Lamy Bernard (Chemin Jules Vuy 23 1227 Carouge CHX), Biodegradable polypeptide and the use thereof for the gradual release of drugs.
  11. Pardridge William M. (Pacific Palisades CA) Schimmel Paul R. (Lexington MA), Chimeric peptides for neuropeptide delivery through the blood-brain barrier.
  12. Pardridge William M. (Van Nuys CA), Chimeric peptides for neuropeptide delivery through the blood-brain barrier.
  13. Porter Garry L. (Wichita KS), Composition and method for protecting a therapeutic drug.
  14. Balasubramanium Ambikaipakan ; Chance William T., Compounds for control of appetite, blood pressure, cardiovascular response, libido, and circadian rhythm.
  15. Tanaka Hiroshi (Chigasaki JPX) Kominato Kaichiro (Yamato JPX) Yoshioka Takeo (Ayase JPX) Iguchi Hiroshi (Yokohama JPX) Hirano Shin-ichi (Chigasaki JPX) Okajima Yasuo (Fujisawa JPX) Yamamoto Reijko (S, Conjugate of adriamycin and cyclodextrin.
  16. Garsky Victor M. ; Defeo-Jones Deborah ; Feng Dong-Mei, Conjugates useful in the treatment of prostate cancer.
  17. Anderson David C. (Seattle WA) Morgan ; Jr. A. Charles (Edmonds WA) Abrams Paul G. (Seattle WA) Fritzberg Alan R. (Edmonds WA) Nichols Everett J. (Seattle WA), Covalently-linked complexes and methods for enhanced cytotoxicity and imaging.
  18. Kosak Kenneth M., Cyclodextrin polymers for carrying and releasing drugs.
  19. Myers Andre E. (Genevea CHX) Bichon Daniel (Thorens-Glieres FRX), Cytotoxic drug conjugates and their delivery to tumor cells.
  20. Stella Valentino J. (Lawrence KS) Mathew Abraham E. (Lenexa KS), Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof.
  21. Shashoua Victor E., Dopamine analog amide.
  22. Victor E. Shashoua, Dopamine analog amide.
  23. Yanaihara Noboru (Shizuoka JA) Igarashi Toshiji (Tokorozawa JA) Kunii Youichi (Funabashi JA), Dopamine derivative compounds, preparation thereof and medicine containing same.
  24. Ordonez Kathy P. (Hoboken NJ) Salamone Salvatore J. (Stockton NJ), Dual analyte immunoassay for methamphetamine and amphetamine.
  25. Wallace Sidney (Houston TX) Yang David (Sugarland TX) Wallace Michael (Houston TX), Efficient microcapsule preparation and method of use.
  26. Cooke John P. ; Dzau Victor J. ; Gibbons Gary H., Enhancement of vascular function by modulation of endogenous nitric oxide production or activity.
  27. Schiffman Elliott (Chevy Chase MD) Altman Leonard C. (Seattle WA), Formyl-methionyl chemotatic peptide antibiotic conjugates useful in treating infections.
  28. Antoni, Ferenc; Erchegyi, Judit; Horvath, Aniko; Keri, Gyorgi; Mezo , Imre; Nikolics, Karoly; Seprodi, Janos; Szell, Andras; Szoke, Balazs; Teplan, Istvan, Gonadoliberin derivatives process for the preparation and pharmaceutical compositions thereof.
  29. Ullman Edwin F. (Atherton CA) Rubenstein Kenneth E. (Menlo Park CA), Iodothyronine enzyme conjugates.
  30. Albarella James P. (Elkhart IN) Carrico Robert J. (Elkhart IN) Li Thomas M. (Elkhart IN), Iodothyronine immunogens and antibodies.
  31. Latham Keith Roger ; Latham Vincent Ernest, Iodothyronine polymers.
  32. Latham Keith Roger ; Latham Vincent Ernest, Iodothyronine polymers.
  33. Katz Robert ; Tomoaia-Cotisel Maria, Lipophilic-polycationic delivery systems.
  34. Jeffrey Dickinson GB; Karrar Ahmad Khan GB; John Neville Hague GB; Alan Smith GB, Liquid pharmaceutical compositions comprising thyroid hormones.
  35. Phillips Christopher P. (Brandamore PA) Snow Robert A. (West Chester PA), Lyophilized polyethylene oxide modified protein and polypeptide complexes with cyclodextrin.
  36. Rothbard Jonathan B. ; Wender Paul A., Method and composition for enhancing transport across biological membranes.
  37. Poduslo Joseph F. (5719 St. Mary\s Dr. NW Rochester MN 55901) Curran Geoffrey L. (629 23rd St. NE Rochester MN 55906), Method to enhance permeability of the blood/brain blood/nerve bariers to therapeutic agents.
  38. Deming, Timothy J., Methods and compositions for controlled polypeptide synthesis.
  39. Deming, Timothy J.; Yu, Miaoer; Curtin, Scott A.; Hwang, Jungyeon; Wyrsta, Michael D., Methods and compositions for controlled polypeptide synthesis.
  40. Deming, Timothy J.; Yu, Miaoer; Curtin, Scott A.; Hwang, Jungyeon; Wyrsta, Michael D.; Nowak, Andrew; Seidel, Scott W., Methods and compositions for controlled polypeptide synthesis.
  41. Lee Vincent H. (Monterey Park CA) Yen Wan-Ching (Columbus OH), Methods and compositions to enhance epithelial drug transport.
  42. Bodor Nicolae S. (Lawrence KS) Sloan Kenneth B. (Lawrence KS) Hussain Anwar A. (Lexington KY), Novel, transient pro-drug forms of L-DOPA.
  43. Borel Yves (Brookline MA) Stollar B. David (Newton MA) Borel Helina (Brookline MA) Gallop Paul M. (Chestnut Hill MA), Oligonucleotide conjugates.
  44. Schneider Richard S. (Saratoga CA) Gould Steven J. (South Windham CT), Oxazepam derivatives for immunoassay reagents.
  45. Dorn Conrad P. (Plainfield NJ) Yang Shu S. (Piscataway NJ), Peptide carbazates and pharmaceutical composition.
  46. Toth Istvan,GBX ; Gibbons William Anthony,GBX, Peptide compounds.
  47. Kabanov Alexander V. ; Alakhov Valery Y.,CAX, Peptide copolymer compositions.
  48. Lazo John S. ; Wipf Peter, Peptidyl prodrugs and methods of making and using the same.
  49. Florvall Gosta Lennart (Sodertalje SW) Ross Svante Bertil (Sodertalje SW) Ogren Sven-Ove (Sodertalje SW), Pharmaceutical compositions containing an amphetamine derivative for the alleviation of anxiety or treatment of depressi.
  50. Kotake Ken-ichiro,JPX ; Kozono Toshiro,JPX ; Sato Tsutomu,JPX ; Takanashi Hisanori,JPX, Phenethylamine derivatives.
  51. Zalipsky Samuel (Princeton NJ) Bolikal Durgadas (Edison NJ) Nathan Aruna (Piscataway NJ) Kohn Joachim B. (Highland Park NJ), Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon.
  52. Summerton James E. ; Weller Dwight D., Polymer composition for delivering substances in living organisms.
  53. Mongelli Nicola (Milan ITX) Angelucci Francesco (Milan ITX) Pesenti Enrico (Cologno Monzese ITX) Suarato Antonino (Milan ITX) Biasoli Giovanni (Gavirate ITX), Polymer-bound paclitaxel derivatives.
  54. Leute Richard K. (Mountain View CA), Polypeptide propoxyphene derivatives for immunoassay reagents.
  55. Janmey Paul A. ; Cunningham C. Casey ; Hartwig John H. ; Stossel Thomas P. ; Vegner Roland,LVX, Polyphoshoinositide binding peptides for intracellular drug delivery.
  56. Bundgaard Hans (Tjornevej 36 DK-2970 Horsholm DKX) Nielsen Niels M. (Cumberlandsgade 15 ; st.th. DK-2300 Copenhagen DKX), Prodrug derivatives of carboxylic acid drugs.
  57. Rips Richard (Paris FRX) Morier Elisabeth (Paris FRX), Pseudopeptides used as medicaments.
  58. Gao, Feng; Miotto, Jahanara, Sugar derivatives of hydromorphone, dihydromorphine and dihydromorphine, compositions thereof and uses for treating or preventing pain.
  59. Couch, Richard A.; Burnside, Beth A.; Chang, Rong-Kun, Sustained release delivery of amphetamine salts.
  60. Jackson, Roy W.; Subasinghe, Kamani R.; Boura, Alan L. A., Therapeutic compounds.
  61. Yager Paul ; Gelb Michael H. ; Carlson Paul A. ; Lee Kyujin C. ; Lukyanov Anatoly N. ; Goldstein Alex S., Therapeutic delivery using compounds self-assembled into high axial ratio microstructures.
  62. Kunz Lawrence L. ; Klein Richard A. ; Reno John M. ; Grainger David J.,GBX ; Metcalfe James C.,GBX ; Weissberg Peter L.,GBX ; Anderson Peter G., Therapeutic inhibitor of vascular smooth muscle cells.
  63. Peterson Robert V. (Murray UT) Anderson James M. (Cleveland Heights OH) Gregonis Donald E. (Salt Lake City UT) Kim Sunj-Wan (Salt Lake City UT) Feijen Jan (Hengelo NLX), Time-release chemical delivery system.
  64. Matzke Michael,DEX ; Militzer Hans-Christian,DEX ; Mittendorf Joachim,DEX ; Kunisch Franz,DEX ; Schmidt Axel,DEX ; Schonfeld Wolfgang,DEX ; Ziegelbauer Karl,DEX, Tolerability of pharmaceutically active .beta.-amino acids.
  65. Uzgiris Egidijus Edward, Tumor targeting with polymeric molecules having extended conformation.
  66. Gross Stanley Joseph (Encino CA), Tyrosyl-class antigenic conjugates, their preparation and antibodies raised thereto.
  67. Li Chun ; Wallace Sidney ; Yu Dong-Fang ; Yang David J., Water soluble paclitaxel prodrugs.

이 특허를 인용한 특허 (20)

  1. Lickrish, David; Zhang, Feng, Compositions for treatment of attention deficit hyperactivity disorder.
  2. Lickrish, David; Zhang, Feng, Compositions for treatment of attention deficit hyperactivity disorder.
  3. Lickrish, David; Zhang, Feng, Compositions for treatment of attention deficit hyperactivity disorder.
  4. Lickrish, David; Zhang, Feng, Compositions for treatment of attention deficit hyperactivity disorder.
  5. Lickrish, David; Zhang, Feng, Compositions for treatment of attention deficit hyperactivity disorder.
  6. Lickrish, David; Zhang, Feng, Compositions for treatment of attention deficit hyperactivity disorder.
  7. Lickrish, David; Zhang, Feng, Compositions for treatment of attention deficit hyperactivity disorder.
  8. Lickrish, David; Zhang, Feng, Compositions for treatment of attention deficit hyperactivity disorder.
  9. Lickrish, David; Zhang, Feng, Compositions for treatment of attention deficit hyperactivity disorder.
  10. Nebuloni, Marino; Colombo, Patrizia, Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride.
  11. Nebuloni, Marino; Colombo, Patrizia, Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride.
  12. Nebuloni, Marino; Colombo, Patrizia, Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride.
  13. Lickrish, David; Zhang, Feng, Method of treatment of attention deficit hyperactivity disorder.
  14. Lederman, Seth; Harris, Herb, Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprine.
  15. Lederman, Seth; Harris, Herbert, Methods and compositions for treating symptoms associated with post-traumatic stress disorder using cyclobenzaprine.
  16. Lickrish, David; Zhang, Feng, Methods and compositions for treatment of attention deficit disorder.
  17. Lickrish, David; Zhang, Feng, Methods for treatment of attention deficit hyperactivity disorder.
  18. Lickrish, David; Zhang, Feng, Methods for treatment of attention deficit hyperactivity disorder.
  19. Lickrish, David; Zhang, Feng, Methods for treatment of attention deficit hyperactivity disorder.
  20. Lickrish, David; Zhang, Feng, Methods of treatment of attention deficit hyperactivity disorder.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트